The Food and Drug Administration is currently reviewing a first-of-its-kind, twice-yearly injectable medication that experts say could revolutionize HIV prevention. The drug, Lenacapavir, has shown ...

People living with HIV have a significantly increased risk of cardiovascular disease that requires a different level of ...

A major bottleneck in curing HIV (human immunodeficiency virus) is that the virus can hide in an inactive form within resting ...

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.

Transmission of human immunodeficiency virus (HIV) from mother to child has increased sharply over the past years, the Department of Health (DOH) reported. In the latest HIV and AIDS (acquired immune ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

The battle against HIV/AIDS has been going more than 40 years.

Dr. Mark Dybul was an architect of PEPFAR, a program credited with saving 26 million lives. Now its future could be in ...

Scientists found a way to make the HIV virus visible, potentially laying the groundwork for ways to banish it from the body ...

HealthDay News — Dispensing and initiation of HIV preexposure prophylaxis (PrEP) among young adults increased from 2016 through 2023, according to a study published online May 9 in the Journal of ...

It’s been a privilege to witness the remarkable progress over the last several decades, with the story of HIV transforming ...

The US Department of Health and Human Services will not extend a grant funding the Center for HIV/AIDS Vaccine Development, ...